Focal Point of Fanconi Anemia Signaling
Open Access
- 30 November 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (23) , 12976
Abstract
Among human genetic diseases, Fanconi Anemia (FA) tops all with its largest number of health complications in nearly all human organ systems, suggesting the significant roles played by FA genes in the maintenance of human health. With the accumulated research on FA, the encoded protein products by FA genes have been building up to the biggest cell defense signaling network, composed of not only 22+ FA proteins but also ATM, ATR, and many other non-FA proteins. The FA D2 group protein (FANCD2) and its paralog form the focal point of FA signaling to converge the effects of its upstream players in response to a variety of cellular insults and simultaneously with downstream players to protect humans from contracting diseases, including aging and cancer. In this review, we update and discuss how the FA signaling crucially eases cellular stresses through understanding its focal point.Keywords
This publication has 101 references indexed in Scilit:
- Fanconi anemia and its diagnosisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2009
- Inactivation of Murine Usp1 Results in Genomic Instability and a Fanconi Anemia PhenotypeDevelopmental Cell, 2009
- FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathwayNature Structural & Molecular Biology, 2008
- Identification of the FANCI Protein, a Monoubiquitinated FANCD2 Paralog Required for DNA RepairCell, 2007
- Loss of expression of FANCD2 protein in sporadic and hereditary breast cancerBreast Cancer Research and Treatment, 2007
- PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 2006
- The DNA helicase BRIP1 is defective in Fanconi anemia complementation group JNature Genetics, 2005
- Checking on DNA damage in S phaseNature Reviews Molecular Cell Biology, 2004
- Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survivalOncogene, 2003
- Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumorsNature Medicine, 2003